Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Forced Expiratory Volume in 1 Second Variability Helps Identify Patients with Cystic Fibrosis at Risk of Greater Loss of Lung Function.

Morgan WJ, VanDevanter DR, Pasta DJ, Foreman AJ, Wagener JS, Konstan MW; Scientific Advisory Group.; Investigators and Coordinators of Epidemiologic Study of Cystic Fibrosis..

J Pediatr. 2016 Feb;169:116-21.e2. doi: 10.1016/j.jpeds.2015.08.042. Epub 2015 Sep 19.

PMID:
26388208
2.

Cavitary lung nodules in a patient with prior squamous cell carcinoma of the submandibular gland.

Kulkarni HS, Rosenbluth DB.

Am J Respir Crit Care Med. 2014 Dec 15;190(12):1447-8. doi: 10.1164/rccm.201408-1493IM. No abstract available.

PMID:
25496104
3.

Gender differences in outcomes of patients with cystic fibrosis.

Harness-Brumley CL, Elliott AC, Rosenbluth DB, Raghavan D, Jain R.

J Womens Health (Larchmt). 2014 Dec;23(12):1012-20. doi: 10.1089/jwh.2014.4985.

4.

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial.

Kerem E, Konstan MW, De Boeck K, Accurso FJ, Sermet-Gaudelus I, Wilschanski M, Elborn JS, Melotti P, Bronsveld I, Fajac I, Malfroot A, Rosenbluth DB, Walker PA, McColley SA, Knoop C, Quattrucci S, Rietschel E, Zeitlin PL, Barth J, Elfring GL, Welch EM, Branstrom A, Spiegel RJ, Peltz SW, Ajayi T, Rowe SM; Cystic Fibrosis Ataluren Study Group..

Lancet Respir Med. 2014 Jul;2(7):539-47. doi: 10.1016/S2213-2600(14)70100-6. Epub 2014 May 15.

5.

Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.

Mayer-Hamblett N, Rosenfeld M, Treggiari MM, Konstan MW, Retsch-Bogart G, Morgan W, Wagener J, Gibson RL, Khan U, Emerson J, Thompson V, Elkin EP, Ramsey BW; EPIC.; ESCF Investigators..

Pediatr Pulmonol. 2013 Oct;48(10):943-53. doi: 10.1002/ppul.22693. Epub 2013 Jul 2.

6.

Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function.

Morgan WJ, Wagener JS, Yegin A, Pasta DJ, Millar SJ, Konstan MW; Scientific Advisory Group, investigators.; coordinators of the Epidemiologic Study of Cystic Fibrosis..

J Pediatr. 2013 Oct;163(4):1152-7.e2. doi: 10.1016/j.jpeds.2013.05.013. Epub 2013 Jun 27.

7.

Effects of puberty on cystic fibrosis related pulmonary exacerbations in women versus men.

Sutton S, Rosenbluth D, Raghavan D, Zheng J, Jain R.

Pediatr Pulmonol. 2014 Jan;49(1):28-35. doi: 10.1002/ppul.22767. Epub 2013 Mar 4.

8.

Pulse lead/lag timing detection for adaptive feedback and control based on optical spike-timing-dependent plasticity.

Fok MP, Tian Y, Rosenbluth D, Prucnal PR.

Opt Lett. 2013 Feb 15;38(4):419-21. doi: 10.1364/OL.38.000419.

PMID:
23455088
9.

Asynchronous spiking photonic neuron for lightwave neuromorphic signal processing.

Fok MP, Tian Y, Rosenbluth D, Prucnal PR.

Opt Lett. 2012 Aug 15;37(16):3309-11. doi: 10.1364/OL.37.003309.

PMID:
23381240
10.

Infection control knowledge, attitudes, and practices among cystic fibrosis patients and their families.

Miroballi Y, Garber E, Jia H, Zhou JJ, Alba L, Quittell LM, Angst D, Cabana M, Saiman L; CF Infection Control Study Consortium..

Pediatr Pulmonol. 2012 Feb;47(2):144-52. doi: 10.1002/ppul.21528. Epub 2011 Aug 24.

PMID:
22241572
11.

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.

Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, Ashlock MA, Ballmann M, Boyle MP, Bronsveld I, Campbell PW, De Boeck K, Donaldson SH, Dorkin HL, Dunitz JM, Durie PR, Jain M, Leonard A, McCoy KS, Moss RB, Pilewski JM, Rosenbluth DB, Rubenstein RC, Schechter MS, Botfield M, OrdoƱez CL, Spencer-Green GT, Vernillet L, Wisseh S, Yen K, Konstan MW.

Thorax. 2012 Jan;67(1):12-8. doi: 10.1136/thoraxjnl-2011-200393. Epub 2011 Aug 8.

12.

A randomized trial of conventional chest physical therapy versus high frequency chest wall compressions in intubated and non-intubated adults.

Clinkscale D, Spihlman K, Watts P, Rosenbluth D, Kollef MH.

Respir Care. 2012 Feb;57(2):221-8. doi: 10.4187/respcare.01299. Epub 2011 Jul 12.

13.

Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with cystic fibrosis.

Schechter MS, McColley SA, Regelmann W, Millar SJ, Pasta DJ, Wagener JS, Konstan MW, Morgan WJ; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis..

J Pediatr. 2011 Nov;159(5):819-824.e1. doi: 10.1016/j.jpeds.2011.05.005. Epub 2011 Jun 25.

14.

Ultrafast all-optical implementation of a leaky integrate-and-fire neuron.

Kravtsov KS, Fok MP, Prucnal PR, Rosenbluth D.

Opt Express. 2011 Jan 31;19(3):2133-47. doi: 10.1364/OE.19.002133.

PMID:
21369031
15.

Signal feature recognition based on lightwave neuromorphic signal processing.

Fok MP, Deming H, Nahmias M, Rafidi N, Rosenbluth D, Tait A, Tian Y, Prucnal PR.

Opt Lett. 2011 Jan 1;36(1):19-21. doi: 10.1364/OL.36.000019.

PMID:
21209673
16.

Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection.

Moskowitz SM, Emerson JC, McNamara S, Shell RD, Orenstein DM, Rosenbluth D, Katz MF, Ahrens R, Hornick D, Joseph PM, Gibson RL, Aitken ML, Benton WW, Burns JL.

Pediatr Pulmonol. 2011 Feb;46(2):184-92. doi: 10.1002/ppul.21350. Epub 2010 Oct 20.

17.

Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax.

Flume PA, Mogayzel PJ Jr, Robinson KA, Rosenblatt RL, Quittell L, Marshall BC; Clinical Practice Guidelines for Pulmonary Therapies Committee.; Cystic Fibrosis Foundation Pulmonary Therapies Committee..

Am J Respir Crit Care Med. 2010 Aug 1;182(3):298-306. doi: 10.1164/rccm.201002-0157CI.

PMID:
20675678
18.

A high performance photonic pulse processing device.

Rosenbluth D, Kravtsov K, Fok MP, Prucnal PR.

Opt Express. 2009 Dec 7;17(25):22767-72. doi: 10.1364/OE.17.022767.

PMID:
20052202
19.

Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis.

Schechter MS, McColley SA, Silva S, Haselkorn T, Konstan MW, Wagener JS; Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.; North American Scientific Advisory Group for ESCF..

J Pediatr. 2009 Nov;155(5):634-9.e1-4. doi: 10.1016/j.jpeds.2009.04.059. Epub 2009 Jul 16.

20.

[18F]fluorodeoxyglucose positron emission tomography for lung antiinflammatory response evaluation.

Chen DL, Bedient TJ, Kozlowski J, Rosenbluth DB, Isakow W, Ferkol TW, Thomas B, Mintun MA, Schuster DP, Walter MJ.

Am J Respir Crit Care Med. 2009 Sep 15;180(6):533-9. doi: 10.1164/rccm.200904-0501OC. Epub 2009 Jul 2.

Supplemental Content

Loading ...
Support Center